Role of Phosphorylation Sites in Desensitization of µ-Opioid Receptor

Arsalan Yousuf1, Elke Miess1, Setareh Sianati1

  • 1Discipline of Pharmacology, University of Sydney, New South Wales, Sydney, Australia (A.Y., S.Si., Y.-P.D., M.J.C.); and Institute of Pharmacology and Toxicology, Jena University Hospital, Friedrich Schiller University Jena, Jena, Germany (E.M., S.Sc.).

Insights

µ-opioid receptor (MOPr) desensitization can occur independently of C-terminal S/T phosphorylation and internalization. However, mutating all C-terminal phosphorylation sites abolishes Met(5)-enkephalin-induced desensitization, indicating phosphorylation is necessary for this specific pathway.

Area of Science:

  • Pharmacology
  • Molecular Biology
  • Neuroscience

Background:

  • Phosphorylation of µ-opioid receptor (MOPr) C-terminal tail residues is implicated in receptor desensitization and internalization.
  • The precise role of C-terminal S/T phosphorylation in MOPr desensitization remains unclear, despite its established requirement for internalization.

Purpose of the Study:

  • To investigate the influence of C-terminal phosphorylation sites on the rapid desensitization of the µ-opioid receptor (MOPr).
  • To determine if MOPr desensitization is dependent on C-terminal S/T phosphorylation and/or receptor internalization.

Main Methods:

  • Stable expression of wild-type MOPr and various C-terminal S/T phosphorylation site mutants (3S/T-A, 6S/T-A, 11S/T-A) in AtT20 cells.
  • Perforated patch-clamp recordings to measure MOPr-mediated G-protein-activated inwardly rectifying potassium channel (GIRK) conductance.
  • Assessment of desensitization induced by Met(5)-enkephalin (ME) and morphine exposure.

Main Results:

  • ME-induced MOPr desensitization was abolished in the 11S/T-A mutant, while the 3S/T-A and 6S/T-A mutants showed no difference from wild-type.
  • Morphine-induced desensitization was unaffected in all mutants, and heterologous desensitization of the somatostatin receptor (SSTR) was also unaffected.
  • Protein kinase C inhibition reduced morphine-induced desensitization in wild-type MOPr and abolished it in the 11S/T-A mutant.

Conclusions:

  • MOPr desensitization can occur independently of C-terminal S/T phosphorylation and internalization.
  • C-terminal phosphorylation is essential for ME-induced MOPr desensitization, as demonstrated by the complete abolition in the 11S/T-A mutant.
  • Different agonists (ME vs. morphine) may utilize distinct desensitization pathways involving C-terminal phosphorylation.

Related Concept Videos

Opioid Receptors: Overview01:22

Opioid Receptors: Overview

Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
6.9K
GPCR Desensitization01:12

GPCR Desensitization

G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
8.9K
Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
3.1K
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
19.6K